Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement
Maisa Yoshimoto(University of Alberta), Jeremy A. Squire(Universidade de São Paulo), Susan Chilton‐MacNeill(Hospital for Sick Children), Jane Bayani(Ontario Institute for Cancer Research), Shamini Selvarajah(University Health Network), Anthony M. Joshua(St Vincent's Hospital Sydney), Maria Zieleńska(University of Toronto), Andrew Evans(University of Dundee)
Cited by 186
Related Papers
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
|The Lancet|2014|1.8k
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
|JAMA|2016|1.1k
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869